Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

780295

registered interest
date	30/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Abortion: Northern Ireland
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what account they took of patient safety and the findings of recent Care Quality Commission reports that Marie Stopes International clinics had been in serious breach of safety guidelines, when deciding to extend the scheme under which free NHS abortions are made available to women from Northern Ireland to include the provision of free travel to those clinics.
tabling member printed	Lord Alton of Liverpool
uin	HL2659
answer	answer is ministerial correction date of answer 13/11/2017 answer text <p>Clinics run by Marie Stopes International (MSI) continue to be registered with the Care Quality Commission (CQC) and approved by the Secretary of State to perform abortions. We are aware that CQC inspections raised serious concerns about compliance by MSI clinics with requirements set by the Department and the CQC. MSI are continuing to take a range of actions to address the issues identified in the CQC’s reports. The CQC re-inspected MSI earlier this year and has made clear that they will not hesitate to take further action if necessary, in order to guarantee MSI meets the standard of care they expect and that its patients deserve. The Department continues to closely monitor the situation with particular regard to the statutory approval responsibilities of the Secretary of State.</p> answering member printed Lord O'Shaughnessy question first answered 13/11/2017 13:56:38 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	738 label Biography information for Lord Alton of Liverpool

780348

registered interest
date	30/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, in the light of reports that drug-related deaths are increasing in the areas of England where cuts to drug treatment budgets have been among the greatest, whether they intend to establish a national inquiry and action plan to tackle this issue in order to reduce the number of deaths.
tabling member printed	Lord Patel of Bradford
uin	HL2712
answer	answer is ministerial correction date of answer 13/11/2017 answer text <p>Public Health England (PHE) led an inquiry last year into the rises in drug-related deaths. The inquiry report, <em>Understanding and preventing drug-related deaths: The report of a national expert working group to investigate drug-related death in England,</em> was published on 9 September 2016 and a copy is attached.</p><p> </p><p>The Government is investing over £16 billion over the current five-year spending review period for local authorities (LAs) to spend on public health. LAs are responsible for making decisions on how to spend their local allocation, but the public health grant conditions make it clear that they must have regard for the need to improve the take up of and outcomes from their drug and alcohol misuse treatment services. Whilst there is considerable variation across the country, with some regions showing large increases in recent years, PHE will continue to support LAs in delivering tailored, accessible and effective services where people stand the best chance of recovery.</p> answering member printed Lord O'Shaughnessy question first answered 13/11/2017 13:58:02 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name Understanding and preventing drug related deaths Sept 2016.pdf title Understanding and preventing drug-related deaths
tabling member	3798 label Biography information for Lord Patel of Bradford

780357

registered interest
date	30/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Aphantasia
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they recognise the condition Aphantasia; and, if so, what support is offered to sufferers.
tabling member printed	Lord Storey
uin	HL2721
answer	answer is ministerial correction date of answer 13/11/2017 answer text <p>Recognition and classification of disorders is a matter for clinicians and academics in the relevant field. Relatively little is known about aphantasia and the impact it may or may not have on health and wellbeing.</p><p> </p><p>If someone believes they may have the condition and it is impacting on their health and wellbeing they should discuss this with their general practitioner.</p> answering member printed Lord O'Shaughnessy question first answered 13/11/2017 13:57:09 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4238 label Biography information for Lord Storey

780491

registered interest
date	30/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Respiratory System: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients were admitted via accident and emergency departments in each month of the last six financial years with (a) asthma, (b) bronchitis and (c) bronchiolitis were aged (i) under one, (ii) one to four, (iii) five to nine, (iv) 10 to 14, (v) 15 to 19 and (vi) 20 to 24.
tabling member constituency	Stockton North
tabling member printed	Alex Cunningham
uin	110457
answer	answer is ministerial correction date of answer 06/11/2017 answer text <p>The information is not collected in the format requested.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 06/11/2017 15:30:49 answering member 1542 label Biography information for Philip Dunne
tabling member	4122 label Biography information for Alex Cunningham

780492

registered interest
date	30/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to recognised local authority mental health services as a key service alongside the NHS and to ensure that the statutory functions of local authority mental health services are adequately funded.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	110445
answer	answer is ministerial correction date of answer 06/11/2017 answer text <p>Local authorities (LAs) have a statutory duty to take the steps that they decide are appropriate to improve the physical and mental health of the people in their areas. It is for individual LAs to identify and address the particular needs of their population. Many of the services they arrange have the potential to benefit mental health and wellbeing, including drug and alcohol misuse treatment. LAs will receive £16 billion over the current five-year spending review period to fund their health improvement activity.</p><p> </p><p>Local authorities also have statutory responsibilities to do with the Mental Health Act. The Care Quality Commission monitors the operation of the Act, and reports to Parliament each year on its findings. The Independent Review of the Mental Health Act will also examine current practice and look at how the Act is working for patients, and how it can be improved.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 06/11/2017 16:25:10 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4658 label Biography information for Alex Sobel

780493

registered interest
date	30/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to improve the sharing of medical records between medical institutions and trusts for mental health service users.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	110444
answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The Government recognises that appropriate and timely sharing of data is essential to improving care, treatment and support for service users. We are committed to ensuring the health and social care system in England realises the benefits of sharing data in a safe, secure and legal way.</p><p> </p><p>Government policy has outlined the importance of sharing data between organisations at a local level. The Department has worked with the Centre of Excellence for Information Sharing to understand the factors which impact on information sharing in mental health crisis care.</p><p> </p><p>Challenges around transferring patient notes and records between different organisations and care settings are recognised and will be addressed, in part, by the move from paper records to electronic systems for recording and sharing patient information.</p><p> </p><p>‘Information: To Share or not to share? The Information Governance Review’ (2013) created a duty on National Health Service trusts to share information. NHS trusts have to demonstrate in their annual information governance return how they are fulfilling this duty.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 07/11/2017 17:11:35 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4658 label Biography information for Alex Sobel

780494

registered interest
date	30/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether it is his Department's policy that rules on pharmacy supervision should be changed to all non-pharmacists to supervise the sale and supply of prescription medicines; and if he will make a statement.
tabling member constituency	Workington
tabling member printed	Sue Hayman
uin	110277
answer	answer is ministerial correction date of answer 02/11/2017 answer text <p>The Government has not received any recommendations from the Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board to allow non-pharmacists to supervise the sale and supply of prescription medicines. In keeping with its terms of reference, the Rebalancing Programme Board is giving very careful consideration to the supervision of the sale and supply of medicines and the roles of registered pharmacists and registered pharmacy technicians, under the guidance of the four UK Chief Pharmaceutical Officers. Only when the Board has firm proposals will it make recommendations to Ministers and the devolved administrations. Any changes to legislation will be subject to full public consultation, including the completion of an impact assessment, underpinned by a quality systems approach, which maintains patient and public safety.</p><p> </p><p>The Rebalancing Programme Board meets regularly according to business need, having met three times in the last year. Full terms of reference and minutes of the meetings are published at:</p><p><a href="https://www.gov.uk/government/groups/pharmacy-regulation-programme-board" target="_blank">https://www.gov.uk/government/groups/pharmacy-regulation-programme-board</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110278 110279 110280 question first answered 02/11/2017 12:24:05 answering member 4067 label Biography information for Steve Brine
tabling member	4395 label Biography information for Baroness Hayman of Ullock

780495

registered interest
date	30/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: Hospital Beds
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that (a) there are sufficient psychiatric beds to meet demand and (b) out-of-area placements are avoided.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	110274
answer	answer is ministerial correction date of answer 06/11/2017 answer text <p><strong></strong></p><p>My Rt. hon. Friend the Secretary of State for Health is committed to ensuring that patients with mental health conditions can receive treatment as close as possible to where they live. Inappropriate out of area placements are unacceptable and the Government has set a target to eliminate these in non-specialist, acute mental health care by 2020/21.</p><p> </p><p>To support the delivery of this ambition, in October 2016 the Government put in place the first data collection to secure much-needed national transparency on the number of patients that are sent out of their local area for acute inpatient treatment.</p><p> </p><p>NHS England is using this new data to support local health systems to develop and deliver trajectories to eliminate inappropriate out of area placements.</p><p> </p><p>More than £400 million has been made available for investment in mental health crisis resolution home treatment teams over the next four years, enabling them to provide 24/7 crisis response and intensive home treatment as a genuine alternative to admission where appropriate.</p><p> </p><p>Shared learning and best-practice advice on reducing out of area placements through improved system capacity management will be included in acute care commissioning guidance.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 06/11/2017 11:42:23 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4658 label Biography information for Alex Sobel

780496

registered interest
date	30/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many Yellow Cards submitted to the Medicines and Healthcare Products Regulatory Agency on the HPV vaccination have been classified as serious in the last three years.
tabling member constituency	Mansfield
tabling member printed	Ben Bradley
uin	110248
answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) encourages anyone to report a suspected adverse reaction (ADR) to a vaccine or medicine through the Yellow Card Scheme:</p><p> </p><p><a href="http://www.mhra.gov.uk/yellowcard" target="_blank">www.mhra.gov.uk/yellowcard</a></p><p>A Yellow Card report is not proof of a side effect occurring, but a suspicion by the reporter that the vaccine or medicine may have been the cause. Such reports are kept under continual review to identify potential new risks.</p><p> </p><p>Between 31 October 2014 – 30 October 2017 a total of 649 serious suspected adverse reaction (ADR) reports with human papilloma virus (HPV) vaccines have been reported to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card Scheme (data run date: 1 November 2017). In this three year period, at least 1 million doses of HPV vaccine were administered in the United Kingdom.</p><p> </p><p>A breakdown of UK serious suspected spontaneous ADR reports received via the Yellow Card Scheme beween 31 October 2014 – 30 October 2016 by brand and year received is shown in the following table.</p><p> </p><table><tbody><tr><td><p>HPV Vaccine</p></td><td><p>Number of serious reports</p></td></tr><tr><td><p>HPV brand unspecified</p></td><td><p>181</p></td></tr><tr><td><p>Cervarix</p></td><td><p>64</p></td></tr><tr><td><p>Gardasil</p></td><td><p>390</p></td></tr><tr><td><p>Gardasil 9</p></td><td><p>18</p></td></tr><tr><td><p>Total</p></td><td><p>649</p></td></tr></tbody></table><p> </p><p>Source: MHRA sentinel database for adverse reactions</p><p> </p><p>Notes:</p><p> </p><p>The total number of reports received by vaccine brand is not equal to the totals in the table above as some reports included more than one HPV vaccine brand.</p><p> </p><p>The MHRA has received a total of 3,159 serious suspected adverse reaction reports associated with HPV vaccine (data run date 1 November 2017).</p><p> </p><p>All serious reports received via the Yellow Card Scheme are reviewed based on the details received from the reporter. Follow up letters may be sent for missing information such as vaccine brand name, batch number, medical history, results of investigations, diagnoses and details of outcome.</p><p> </p><p>The Commission on Human Medicines has thoroughly reviewed the safety of HPV vaccines and concluded that the evidence does not support a link between HPV vaccination and the development of chronic illnesses.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 110360 question first answered 07/11/2017 11:31:40 answering member 4067 label Biography information for Steve Brine
tabling member	4663 label Biography information for Ben Bradley

780497

registered interest
date	30/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Care Homes: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with Cabinet colleagues on the potential merits of introducing a cap on care costs for older people.
tabling member constituency	Stafford
tabling member printed	Jeremy Lefroy
uin	110249
answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The Government will work to address the challenges of social care for our ageing population, bringing forward proposals for consultation to build widespread support. We are committed to listening to people’s views on how to reform the social care system, to ensure it is sustainable for current and future generations and that the quality of care improves.</p><p> </p><p>Ageing and care issues span a number of areas for which different Departments have policy responsibility, which is why the Cabinet Office will continue to coordinate this work through its next phase, working closely with HM Treasury and the Departments of Health, Communities and Local Government, Work and Pensions, and Business, Energy and Industrial Strategy.</p><p> </p><p>We will consult on options which will include a capital floor and an absolute limit on the amount people who can be asked to pay, and are keen to hear different views on the cap, both its level and design.</p><p> </p><p>We will provide further details on the next steps on social care in due course.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 110250 question first answered 07/11/2017 17:09:59 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4109 label Biography information for Jeremy Lefroy